Risk and protective factors of drug abuse among adolescents: a systematic review
Background Drug abuse is detrimental, and excessive drug usage is a worldwide problem.
Drug usage typically begins during adolescence. Factors for drug abuse include a variety of …
Drug usage typically begins during adolescence. Factors for drug abuse include a variety of …
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Objective To systematically assess credibility and certainty of associations between
cannabis, cannabinoids, and cannabis based medicines and human health, from …
cannabis, cannabinoids, and cannabis based medicines and human health, from …
Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis
Importance Cannabis is the most commonly used drug of abuse by adolescents in the world.
While the impact of adolescent cannabis use on the development of psychosis has been …
While the impact of adolescent cannabis use on the development of psychosis has been …
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis
Background Comorbidity is highly prevalent between substance use disorders (SUDs) and
schizophrenia. This systematic review and meta-analysis estimated prevalence rates of …
schizophrenia. This systematic review and meta-analysis estimated prevalence rates of …
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational …
This review examines evidence for the effectiveness of cannabinoids in chronic noncancer
pain (CNCP) and addresses gaps in the literature by: considering differences in outcomes …
pain (CNCP) and addresses gaps in the literature by: considering differences in outcomes …
A review of the potential use of pinene and linalool as terpene-based medicines for brain health: discovering novel therapeutics in the flavours and fragrances of …
K Weston-Green, H Clunas… - Frontiers in psychiatry, 2021 - frontiersin.org
“Medicinal cannabis” is defined as the use of cannabis-based products for the treatment of
an illness. Investigations of cannabis compounds in psychiatric and neurological illnesses …
an illness. Investigations of cannabis compounds in psychiatric and neurological illnesses …
Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study
BackgroundSmoking prevalence is higher amongst individuals with schizophrenia and
depression compared with the general population. Mendelian randomisation (MR) can …
depression compared with the general population. Mendelian randomisation (MR) can …
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Background Medicinal cannabis has received increased research attention over recent
years due to loosening global regulatory changes. Medicinal cannabis has been reported to …
years due to loosening global regulatory changes. Medicinal cannabis has been reported to …
Meta-analysis of the association between the level of cannabis use and risk of psychosis
A Marconi, M Di Forti, CM Lewis… - Schizophrenia …, 2016 - academic.oup.com
Cannabis use has been reported to induce long-lasting psychotic disorders and a dose-
response relationship has been observed. We performed a systematic review of studies that …
response relationship has been observed. We performed a systematic review of studies that …
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability
Cannabis use is a heritable trait that has been associated with adverse mental health
outcomes. In the largest genome-wide association study (GWAS) for lifetime cannabis use to …
outcomes. In the largest genome-wide association study (GWAS) for lifetime cannabis use to …